Kazuya Tatani

This inventor holds 12 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd.. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuya Tatani. Retrieved from https://idiyas.com/inventor/kazuya-tatani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 25.0

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 100(Granted Patents)

Location History:

Matsumoto, JP (2007)
Nagano, JP (2006 - 2014)
Azumino, JP (2014)

Company Filing History:

12 out of 176

Kissei Pharmaceutical Co., Ltd.

patents

2 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2006-2014

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8815903 - Indole derivative and pharmacologically acceptable salt thereof (2014-08-26),

2. 8796247 - Indole derivative, and pharmacologically acceptable salt thereof (2014-08-05),

3. 8680120 - Indole derivative or pharmaceutically acceptable salt thereof (2014-03-25),

4. 7795236 - Purine nucleoside derivative modified in 8-position and medical use thereof (2010-09-14),

5. 7547680 - Benzimidazole derivatives and medical uses thereof (2009-06-16),

6. 7541341 - Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof (2009-06-02),

7. 7465712 - Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives (2008-12-16),

8. 7371730 - Crystals of glucopyranosyloxybenzyl benzene derivative (2008-05-13),

9. 7271153 - Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor (2007-09-18),

10. 7129381 - Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof (2006-10-31),

11. 7053060 - Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof (2006-05-30),

12. 7045665 - Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives (2006-05-16),

Title: Kazuya Tatani: Innovator in Pharmaceutical Chemistry

Introduction

Kazuya Tatani is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various medical conditions. With a total of 12 patents to his name, Tatani's work has the potential to impact the treatment of numerous health issues.

Latest Patents

Tatani's latest patents include innovative compounds that exhibit EPreceptor antagonism. One such invention is an indole derivative and its pharmacologically acceptable salt, which can be used as an agent for treating or preventing lower urinary tract symptoms (LUTS), particularly in relation to overactive bladder (OAB) symptoms. The compound is represented by a general formula that includes various functional groups, showcasing Tatani's expertise in medicinal chemistry.

Career Highlights

Throughout his career, Kazuya Tatani has worked with notable companies in the pharmaceutical industry, including Kissei Pharmaceutical Co., Ltd. and Kyorin Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.

Collaborations

Tatani has collaborated with esteemed colleagues such as Masayuki Isaji and Nobuhiko Fushimi. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kazuya Tatani is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of medical conditions. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

Profile summary based on public USPTO records.